This page is a guide to BBC, the BioShares Biotechnology Clinical Trials offered by BioShares.
Last Price
$16.69
+0.41%
How is BBC Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does BBC Compare to Its Category Competitors?
The percentile shown for each metric indicates how BBC compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$15.34
12th Percentile
Dividend Yield
0.77%
19th Percentile
Returns
YTD Return
-33.93%
0th Percentile
5 Year Return
N/A
N/A
Portfolio
Number of Holdings
89
71st Percentile
% Assets in Top 10
15.01%
91st Percentile
Expenses
Expense Ratio
0.85%
7th Percentile
Fund Turnover
N/A
N/A
BBC vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for BBC as well as all other ETFs in the Sector Stock category. To compare BBC to its broader asset class peer group, visit the Stock page. To compare BBC to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for BBC and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 33.14% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.79% |
BBC Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 95.90% |
| Non US Stock Weighting | 4.10% |
| Top Holdings | Weight |
|---|---|
| Inovio Pharmaceuticals Inc | 1.76% |
| uniQure NV | 1.69% |
| Versartis Inc | 1.59% |
| Dynavax Technologies Corp | 1.54% |
| Five Prime Therapeutics Inc | 1.48% |
| Paratek Pharmaceuticals Inc | 1.42% |
| Advaxis Inc | 1.39% |
| Ignyta Inc | 1.39% |
| Infinity Pharmaceuticals Inc | 1.38% |
| Agios Pharmaceuticals Inc | 1.36% |
Other BBC Metrics
Management
- Issuer
- BioShares
- Inception Date
- 12/16/2014
- Management Style
- Passive
- Benchmark
- BioShares Biotech Clin Trials TR USD
Dividend Data
- Dividend Frequency
- Quarterly
- Capital Gains Frequency
- N/A
- Annual Dividend
- N/A
Pricing Data
- Day Range
- $16.12 / $16.83
- Bid/Ask
- $16.66 / $16.76
- 52 Week Low/High
- $16.06 / $40.13
Other Information
- Leveraged Fund
- No
